Masitinib in the Treatment of Active Rheumatoid Arthritis: Results of a Multicentre, Open-Label, Dose-Ranging, Phase 2a Study
Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2740
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2009
Authors
Publisher
Springer Science and Business Media LLC